FDA Recalls 11,460 Chlorthalidone Bottles Over 25 mg Tablet Ineffectiveness
Updated
Updated · WSFA · Jun 22
FDA Recalls 11,460 Chlorthalidone Bottles Over 25 mg Tablet Ineffectiveness
3 articles · Updated · WSFA · Jun 22
Summary
11,460 bottles of chlorthalidone tablets, USP, 25 mg were recalled after the FDA said the blood pressure drug failed dissolution specifications, raising the risk that doses may be ineffective.
The recall covers 100-tablet bottles from batch RISA24001 and 1,000-tablet bottles from batch RISB24002, with an expiration date of April 2027.
Chlorthalidone is a diuretic used to treat high blood pressure and fluid retention linked to conditions including congestive heart failure, severe liver disease and kidney disease.
The issue centers on drug performance rather than contamination, meaning affected tablets may not dissolve properly enough to deliver the intended effect.